Title: Canagliflozin prevents scopolamine-induced memory impairment in rats: Comparison with galantamine hydrobromide action.

Journal: Chemico-biological interactions20171101

Title: Zebrafish biosensor for toxicant induced muscle hyperactivity.

Journal: Scientific reports20160101

Title: Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.

Journal: Neuroscience20150709

Title: Cloning and characterization of a norbelladine 4'-O-methyltransferase involved in the biosynthesis of the Alzheimer's drug galanthamine in Narcissus sp. aff. pseudonarcissus.

Journal: PloS one20140101

Title: Simultaneous quantification of Amaryllidaceae alkaloids from Zephyranthes grandiflora by UPLC-DAD/ESI-MS/MS.

Journal: Journal of pharmaceutical and biomedical analysis20121201

Title: Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Journal: Bioorganic & medicinal chemistry20121115

Title: Food-drug interactions: effect of capsaicin on the pharmacokinetics of galantamine in rats.

Journal: Xenobiotica; the fate of foreign compounds in biological systems20121101

Title: Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.

Journal: International journal of pharmaceutics20121015

Title: Quantification of galantamine in human plasma by validated liquid chromatography-tandem mass spectrometry using glimepride as an internal standard: application to bioavailability studies in 32 healthy Korean subjects.

Journal: Journal of chromatographic science20121001

Title: Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry.

Journal: Journal of computer-aided molecular design20121001

Title: Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20120901

Title: Effects of fungicides on galanthamine and metabolite profiles in Narcissus bulbs.

Journal: Plant physiology and biochemistry : PPB20120901

Title: High-performance liquid chromatography with fast-scanning fluorescence detection and multivariate curve resolution for the efficient determination of galantamine and its main metabolites in serum.

Journal: Analytica chimica acta20120831

Title: Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking.

Journal: Molecules (Basel, Switzerland)20120824

Title: Effect on cognition of galanthamine administered for neuromuscular block reversal in octogenarians undergoing cataract surgery.

Journal: Anaesthesiology intensive therapy20120808

Title: Production of galanthamine by Leucojum aestivum shoots grown in different bioreactor systems.

Journal: Applied biochemistry and biotechnology20120801

Title: GC-MS of amaryllidaceous galanthamine-type alkaloids.

Journal: Journal of mass spectrometry : JMS20120801

Title: Two galantamine titration regimens in patients switched from donepezil.

Journal: Acta neurologica Scandinavica20120701

Title: 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration.

Journal: Lipids20120701

Title: Galantamine administration in chronic post-stroke aphasia.

Journal: Journal of neurology, neurosurgery, and psychiatry20120701

Title: Galantamine effect on tularemia pathogenesis in a BALB/c mouse model.

Journal: Iranian biomedical journal20120701

Title: Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.

Journal: European archives of psychiatry and clinical neuroscience20120601

Title: Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and γ-secretase inhibition activities.

Journal: Current Alzheimer research20120601

Title: Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats.

Journal: Neuropharmacology20120601

Title: Total synthesis of (-)-galanthamine and (-)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive Heck cyclization.

Journal: Organic letters20120601

Title: Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity--application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control.

Journal: European journal of clinical pharmacology20120501

Title: Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS.

Journal: Journal of pharmaceutical and biomedical analysis20120501

Title: Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?

Journal: American journal of Alzheimer's disease and other dementias20120501

Title: Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses.

Journal: Drugs20120416

Title: Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current.

Journal: European journal of pharmacology20120415

Title: New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Journal: British journal of clinical pharmacology20120401

Title: Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.

Journal: Psychopharmacology20120401

Title: Drugs for Alzheimer's disease.

Journal: British journal of clinical pharmacology20120401

Title: Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.

Journal: The Annals of pharmacotherapy20120401

Title: Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.

Journal: Cold Spring Harbor perspectives in medicine20120301

Title: Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation.

Journal: Neuropharmacology20120201

Title: [Pharmacological profiles of galantamine: the involvement of muscarinic receptor].

Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology20120201

Title: Acetylcholinesterase inhibitors for schizophrenia.

Journal: The Cochrane database of systematic reviews20120118

Title: Alkaloid patterns in Leucojum aestivum shoot culture cultivated at temporary immersion conditions.

Journal: Journal of plant physiology20120115

Title: Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats.

Journal: Current Alzheimer research20120101

Title: Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors.

Journal: Journal of Alzheimer's disease : JAD20120101

Title: The economic impact of galantamine vs placebo: an analysis based on functional capacity in a Swedish cohort study.

Journal: Journal of medical economics20120101

Title: The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Journal: Health technology assessment (Winchester, England)20120101

Title: [New anti-AD drugs--their possibilities and issues].

Journal: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica20120101

Title: A novel subject synchronization clinical trial design for Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD20120101

Title: A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.

Journal: The journal of nutrition, health & aging20120101

Title: Controlled release reservoir mini tablets approach for controlling the drug release of Galantamine Hydrobromide.

Journal: Pharmaceutical development and technology20120101

Title: Donepezil, but not galantamine, blocks muscarinic receptor-mediated in vitro and in vivo responses.

Journal: Synapse (New York, N.Y.)20111201

Title: Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance.

Journal: Neurotoxicology20111201

Title: Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus.

Journal: Neuropharmacology20111201

Title: Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram.

Journal: Biochimica et biophysica acta20111201

Title: Medicinal plants and dementia therapy: herbal hopes for brain aging?

Journal: CNS neuroscience & therapeutics20111201

Title: [Galantamine].

Journal: Nihon rinsho. Japanese journal of clinical medicine20111201

Title: Kinetic study of the rearrangement of deuterium-labeled 4'-O-methylnorbelladine in Leucojum aestivum shoot cultures by mass spectrometry. Influence of precursor feeding on amaryllidaceae alkaloid accumulation.

Journal: Journal of natural products20111128

Title: Acetylcholinesterase-inhibiting alkaloids from Zephyranthes concolor.

Journal: Molecules (Basel, Switzerland)20111115

Title: Galantamine and behavior in Alzheimer disease: analysis of four trials.

Journal: Acta neurologica Scandinavica20111101

Title: BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.

Journal: European journal of clinical pharmacology20111101

Title: Effects of galantamine in Alzheimer's disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment.

Journal: Current Alzheimer research20111101

Title: Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.

Journal: Hormones and behavior20111101

Title: Effective pharmacological management of Alzheimer's disease.

Journal: The American journal of managed care20111101

Title: The costs of Alzheimer's disease and the value of effective therapies.

Journal: The American journal of managed care20111101

Title: Galantamine rescues lead-impaired synaptic plasticity in rat dentate gyrus.

Journal: Toxicology20111028

Title: Structural features and hydrogen-bond properties of galanthamine and codeine: an experimental and theoretical study.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)20111004

Title: Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation.

Journal: Bioorganic & medicinal chemistry letters20111001

Title: Pharmacological treatment of Alzheimer disease.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie20111001

Title: The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.

Journal: Behavioural brain research20110930

Title: Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation.

Journal: Hippocampus20110901

Title: Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.

Journal: Pharmacology, biochemistry, and behavior20110901

Title: An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production.

Journal: Mini reviews in medicinal chemistry20110901

Title: Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.

Journal: Expert opinion on investigational drugs20110901

Title: Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry20110901

Title: [Pharmacological and clinical profiles of galantamine (Reminyl(®))].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20110901

Title: Asymmetric synthesis of bioactive hydrodibenzofuran alkaloids: (-)-lycoramine, (-)-galanthamine, and (+)-lunarine.

Journal: Angewandte Chemie (International ed. in English)20110822

Title: Alkaloids from Hippeastrum papilio.

Journal: Molecules (Basel, Switzerland)20110818

Title: Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot study.

Journal: The American journal of geriatric pharmacotherapy20110801

Title: [Newly approved drugs for Alzheimer disease: effectiveness and limitation].

Journal: Brain and nerve = Shinkei kenkyu no shinpo20110801

Title: New drugs for Alzheimer's disease in Japan.

Journal: Psychiatry and clinical neurosciences20110801

Title: Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population.

Journal: Geriatrics & gerontology international20110701

Title: [Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales].

Journal: Psychiatrische Praxis20110701

Title: [Prescription differences of dementia drugs in urban and rural areas in Germany].

Journal: Psychiatrische Praxis20110701

Title: Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.

Journal: The international journal of neuropsychopharmacology20110601

Title: Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat.

Journal: Brain research bulletin20110530

Title: Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats.

Journal: The International journal of neuroscience20110501

Title: Effects of galantamine on cocaine use in chronic cocaine users.

Journal: The American journal on addictions20110501

Title: Stability-indicating study of the anti-Alzheimer's drug galantamine hydrobromide.

Journal: Journal of pharmaceutical and biomedical analysis20110428

Title: Effect of fertilizers on galanthamine and metabolite profiles in Narcissus bulbs by 1H NMR.

Journal: Journal of agricultural and food chemistry20110413

Title: Switching cholinesterase inhibitors in older adults with dementia.

Journal: International psychogeriatrics20110401

Title: Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.

Journal: Journal of proteome research20110401

Title: Synthesis of (-)-homogalanthamine from naltrexone.

Journal: The Journal of organic chemistry20110401

Title: Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.

Journal: Bioorganic & medicinal chemistry20110401

Title: Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome.

Journal: American journal of medical genetics. Part A20110401

Title: Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.

Journal: Prescrire international20110401

Title: Prescribing trends in cognition enhancing drugs in Australia.

Journal: International psychogeriatrics20110301

Title: Molecular cloning and characterization of a phenylalanine ammonia-lyase gene (LrPAL) from Lycoris radiata.

Journal: Molecular biology reports20110301

Title: Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus.

Journal: Neuroscience research20110301

Title: Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.

Journal: Drug metabolism and disposition: the biological fate of chemicals20110301

Title: Long-term response to galantamine in relation to short-term efficacy data: pooled analysis in patients with mild to moderate Alzheimer's disease.

Journal: Current Alzheimer research20110301

Title: Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study.

Journal: Journal of neural transmission (Vienna, Austria : 1996)20110301

Title: Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability.

Journal: International journal of geriatric psychiatry20110301

Title: Development and validation of a GC-MS method for rapid determination of galanthamine in Leucojum aestivum and Narcissus ssp.: a metabolomic approach.

Journal: Talanta20110215

Title: Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.

Journal: The Gerontologist20110201

Title: Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.

Journal: Schizophrenia research20110201

Title: Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method.

Journal: Nanomedicine : nanotechnology, biology, and medicine20110201

Title: Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.

Journal: British journal of pharmacology20110201

Title: Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.

Journal: Behavioural pharmacology20110201

Title: Safety and tolerability of galantamine SA in dementia patients transitioned from donepezil.

Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists20110201

Title: Galantamine improves sustained attention in chronic cocaine users.

Journal: Experimental and clinical psychopharmacology20110201

Title: Ion mobility spectrometry: a valuable tool for kinetic studies in enzymology.

Journal: Analytica chimica acta20110124

Title: Galanthamine and related alkaloids production by Leucojum aestivum L. shoot culture using a temporary immersion technology.

Journal: Applied biochemistry and biotechnology20110101

Title: Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment.

Journal: Alzheimer disease and associated disorders20110101

Title: Respiratory myoclonus, a side effect of galantamine.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria20110101

Title: Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients.

Journal: Journal of Alzheimer's disease : JAD20110101

Title: Alkaloid diversity in Galanthus elwesii and Galanthus nivalis.

Journal: Chemistry & biodiversity20110101

Title: Pharmacological aspects of the acetylcholinesterase inhibitor galantamine.

Journal: Journal of pharmacological sciences20110101

Title: [Cholinesterase blockers in anesthesiology: a replenishment of former arsenal].

Journal: Anesteziologiia i reanimatologiia20110101

Title: Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.

Journal: Journal of Alzheimer's disease : JAD20110101

Title: Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice.

Journal: Molecular medicine (Cambridge, Mass.)20110101

Title: Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study.

Journal: Journal of Alzheimer's disease : JAD20110101

Title: [Sleep disorders in patients with dementia in Parkinson's disease].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20110101

Title: [The application of multichannel electrostimulation and nivalin electrophoresis for the rehabilitative treatment of the patient following plastic surgery in the facial region].

Journal: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury20110101

Title: Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.

Journal: Scientific reports20110101

Title: [The application of electrical stimulation by bipolar pulsed currents and galanthamine electrophoresis for the rehabilitation of patients with diabetes mellitus].

Journal: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury20110101

Title: Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.

Journal: The Journal of biological chemistry20101217

Title: Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain.

Journal: Journal of receptor and signal transduction research20101201

Title: Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.

Journal: The international journal of neuropsychopharmacology20101101

Title: Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells.

Journal: Experimental gerontology20101101

Title: Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress.

Journal: Neurochemistry international20101101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: [Beneficial effect of galantamine on sensory information-processing deficits].

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan20101001

Title: Effects of cholinergic agonists and antagonists under conditions of spleen denervation in rats with endotoxic shock.

Journal: Bulletin of experimental biology and medicine20101001

Title: Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.

Journal: The American journal of geriatric pharmacotherapy20101001

Title: Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association20100901

Title: Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.

Journal: Journal of pineal research20100901

Title: Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus.

Journal: The Journal of pharmacology and experimental therapeutics20100901

Title: Current treatments for patients with Alzheimer disease.

Journal: The Journal of the American Osteopathic Association20100901

Title: Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells.

Journal: Neuroscience letters20100823

Title: Predictors of adherence among Alzheimer's disease patients receiving oral therapy.

Journal: Current medical research and opinion20100801

Title: Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.

Journal: Drugs & aging20100801

Title: Determination of galanthamine in Bulbus Lycoridis Radiatae by coupling capillary electrophoresis with end-column electrochemiluminescence detection.

Journal: Journal of separation science20100801

Title: Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis.

Journal: Chinese medical journal20100701

Title: Spectrofluorimetry in organized media coupled to second-order multivariate calibration for the determination of galantamine in the presence of uncalibrated interferences.

Journal: Talanta20100630

Title: Young and older good learners have higher levels of brain nicotinic receptor binding.

Journal: Neurobiology of aging20100601

Title: Synthesis of 4-[(diethylamino)methyl]-phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase.

Journal: Bioorganic & medicinal chemistry letters20100601

Title: Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia.

Journal: Experimental brain research20100601

Title: The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease.

Journal: Psychiatria Danubina20100601

Title: [Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands].

Journal: Tijdschrift voor gerontologie en geriatrie20100601

Title: Semisynthesis and acetylcholinesterase inhibitory activity of stemofoline alkaloids and analogues.

Journal: Journal of natural products20100528

Title: Galantamine inhibits slowly inactivating K+ currents with a dual dose-response relationship in differentiated N1E-115 cells and in CA1 neurones.

Journal: European journal of pharmacology20100525

Title: Total synthesis of (+/-)-galanthamine via a C3-selective Stille coupling and IMDA cycloaddition cascade of 3,5-dibromo-2-pyrone.

Journal: Organic letters20100507

Title: A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy subjects and patients.

Journal: Current clinical pharmacology20100501

Title: Anticholinesterase duration in the Australian veteran population.

Journal: The Australian and New Zealand journal of psychiatry20100501

Title: Alternative method of oral dosing for rats.

Journal: Journal of the American Association for Laboratory Animal Science : JAALAS20100501

Title: [Variability and trends in dementia drug consumption in Castile-La Mancha (Spain). Estimated prevalence of Alzheimer's disease].

Journal: Neurologia (Barcelona, Spain)20100501

Title: Super-short solid silicon microneedles for transdermal drug delivery applications.

Journal: International journal of pharmaceutics20100415

Title: Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology20100301

Title: Prescribing of drugs for Alzheimer's disease: a South African database analysis.

Journal: International psychogeriatrics20100301

Title: Galantamine for Alzheimer's disease.

Journal: Expert opinion on drug metabolism & toxicology20100301

Title: Reversible acetylcholinesterase inhibitory effect of Tabernaemontana divaricata extract on synaptic transmission in rat CA1 hippocampus.

Journal: The Indian journal of medical research20100301

Title: The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.

Journal: International journal of geriatric psychiatry20100201

Title: Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.

Journal: Progress in neuro-psychopharmacology & biological psychiatry20100201

Title: [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].

Journal: Journal des maladies vasculaires20100201

Title: Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.

Journal: CNS drugs20100201

Title: Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways.

Journal: Current neurovascular research20100201

Title: Galantamine does not cause aggravated orthostatic hypotension in people with Alzheimer's disease.

Journal: Journal of the American Geriatrics Society20100201

Title: Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.

Journal: Cell death & disease20100201

Title: Probing Torpedo californica acetylcholinesterase catalytic gorge with two novel bis-functional galanthamine derivatives.

Journal: Journal of medicinal chemistry20100128

Title: Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy.

Journal: Journal of molecular neuroscience : MN20100101

Title: The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.

Journal: Journal of molecular neuroscience : MN20100101

Title: Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.

Journal: Journal of molecular neuroscience : MN20100101

Title: Analysis of metabolic variation and galanthamine content in Narcissus bulbs by 1H NMR.

Journal: Phytochemical analysis : PCA20100101

Title: Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.

Journal: Neurotoxicology20100101

Title: Promotion effect of norgalanthamine, a component of Crinum asiaticum, on hair growth.

Journal: European journal of dermatology : EJD20100101

Title: Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.

Journal: European journal of medicinal chemistry20100101

Title: Frontotemporal dementia and pharmacologic interventions.

Journal: The Journal of neuropsychiatry and clinical neurosciences20100101

Title: Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease.

Journal: Clinical interventions in aging20100101

Title: Cholinergic sensitivity of the developing bullfrog (Rana catesbeiana) does not explain vulnerability to chronic nicotine exposure.

Journal: Advances in experimental medicine and biology20100101

Title: Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.

Journal: Dementia and geriatric cognitive disorders20100101

Title: Important groups of alkaloids derived biosynthetically from phenylalanine and tyrosine. Preface.

Journal: The Alkaloids. Chemistry and biology20100101

Title: Galanthamine from Galanthus and other Amaryllidaceae--chemistry and biology based on traditional use.

Journal: The Alkaloids. Chemistry and biology20100101

Title: Galanthamine production by Leucojum aestivum cultures in vitro.

Journal: The Alkaloids. Chemistry and biology20100101

Title: New prospectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: in vivo animal studies.

Journal: Current pharmaceutical design20100101

Title: Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use.

Journal: Journal of Alzheimer's disease : JAD20100101

Title: Alkaloid accumulation in different parts and ages of Lycoris chinensis.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences20100101

Title: Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature.

Journal: BMC psychiatry20100101

Title: Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany.

Journal: Journal of medical economics20100101

Title: Effect of elevated intra-abdominal pressure on the contractile activity and reactivity of smooth muscle tissue from rat gastrointestinal tract to galantamine and drotaverine (No-Spa).

Journal: Folia medica20100101

Title: [Cholinesterase inhibitors for treating dementia. Review].

Journal: Vertex (Buenos Aires, Argentina)20100101

Title: Dementia.

Journal: BMJ clinical evidence20100101

Title: Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

Journal: International psychogeriatrics20091201

Title: International price comparisons of Alzheimer's drugs: a way to close the affordability gap.

Journal: International psychogeriatrics20091201

Title: Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.

Journal: The Journal of pharmacology and experimental therapeutics20091201

Title: Metabolic profiling of rat brain and cognitive behavioral tasks: potential complementary strategies in preclinical cognition enhancement research.

Journal: Journal of proteome research20091201

Title: Comparative effectiveness research: an approach to avoiding 'overgeneralized medicine'.

Journal: Clinical and translational science20091201

Title: Concise syntheses of (-)-galanthamine and (+/-)-codeine via intramolecular alkylation of a phenol derivative.

Journal: Journal of the American Chemical Society20091111

Title: Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.

Journal: Journal of the American Geriatrics Society20091101

Title: Alzheimer's disease: Seeing the signs early.

Journal: Journal of the American Academy of Nurse Practitioners20091101

Title: Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer.

Journal: Biochemical and biophysical research communications20091030

Title: Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice.

Journal: Neuroscience letters20091025

Title: Galantamine is a novel post-exposure therapeutic against lethal VX challenge.

Journal: Toxicology and applied pharmacology20091015

Title: Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.

Journal: Behavioural brain research20091012

Title: Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.

Journal: International psychogeriatrics20091001

Title: Trospium and cognition in patients with late onset Alzheimer disease.

Journal: The journal of nutrition, health & aging20091001

Title: Study of acetylcholinesterase inhibitors using CE with contactless conductivity detection.

Journal: Electrophoresis20091001

Title: Case report: combined use of donepezil and galantamine in mixed dementia.

Journal: Journal of the American Geriatrics Society20091001

Title: Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.

Journal: Hippocampus20090901

Title: Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial.

Journal: Journal of neurology, neurosurgery, and psychiatry20090901

Title: Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats.

Journal: Journal of the neurological sciences20090815

Title: Cholinesterase inhibitory effects of the extracts and compounds of Maclura pomifera (Rafin.) Schneider.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association20090801

Title: Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease.

Journal: Brain research20090714

Title: Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Journal: Acta pharmacologica Sinica20090701

Title: Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.

Journal: Bioorganic & medicinal chemistry letters20090615

Title: Electroencephalographic effects of galantamine in major depressive disorder.

Journal: Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society20090601

Title: A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder.

Journal: Journal of clinical psychopharmacology20090601

Title: Drug-induced sialorrhoea and excessive saliva accumulation.

Journal: Prescrire international20090601

Title: Galantamine inhibits beta-amyloid aggregation and cytotoxicity.

Journal: Journal of the neurological sciences20090515

Title: Treatment of Alzheimer's disease in the long-term-care setting.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20090515

Title: Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.

Journal: Neuroscience20090505

Title: Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease.

Journal: International journal of geriatric psychiatry20090501

Title: Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.

Journal: Journal of clinical psychopharmacology20090401

Title: Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.

Journal: Journal of chromatography. A20090320

Title: Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats.

Journal: Progress in neuro-psychopharmacology & biological psychiatry20090317

Title: Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines.

Journal: Translational research : the journal of laboratory and clinical medicine20090301

Title: Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation.

Journal: Biological & pharmaceutical bulletin20090301

Title: Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.

Journal: Biological & pharmaceutical bulletin20090301

Title: An unusual case of nightmares with galantamine.

Journal: Journal of the American Geriatrics Society20090301

Title: Characteristic effects of anti-dementia drugs on rat sleep patterns.

Journal: Journal of pharmacological sciences20090301

Title: Bullous pemphigoid precipitated by galantamine hydrobromide.

Journal: Cutis20090301

Title: Alkaloid synthesis and accumulation in Leucojum aestivum in vitro cultures.

Journal: Natural product communications20090301

Title: Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet20090301

Title: Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease.

Journal: Neuroreport20090218

Title: Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils.

Journal: Brain research20090213

Title: Pressurized liquid extraction and anticholinesterase activity-based thin-layer chromatography with bioautography of Amaryllidaceae alkaloids.

Journal: Analytica chimica acta20090209

Title: Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors.

Journal: European journal of medicinal chemistry20090201

Title: Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine.

Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience20090201

Title: Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

Journal: Brain : a journal of neurology20090201

Title: Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease.

Journal: Electrophoresis20090201

Title: Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Journal: Current Alzheimer research20090201

Title: Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.

Journal: Journal of the American Geriatrics Society20090201

Title: Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.

Journal: The European journal of neuroscience20090201

Title: [Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats].

Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology20090201

Title: Galantamine for dementia in people with Down syndrome.

Journal: The Cochrane database of systematic reviews20090121

Title: Analyses of mortality risk in patients with dementia treated with galantamine.

Journal: Acta neurologica Scandinavica20090101

Title: Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.

Journal: Brain, behavior, and immunity20090101

Title: A single in vivo application of cholinesterase inhibitors has neuron type-specific effects on nicotinic receptor activity in guinea pig hippocampus.

Journal: The Journal of pharmacology and experimental therapeutics20090101

Title: A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease.

Journal: Journal of neurology, neurosurgery, and psychiatry20090101

Title: Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.

Journal: Psychopharmacology20090101

Title: The effects of galantamine on psychopathology in chronic stable schizophrenia.

Journal: Clinical neuropharmacology20090101

Title: [Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients].

Journal: Presse medicale (Paris, France : 1983)20090101

Title: The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease.

Journal: The Lancet. Neurology20090101

Title: Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.

Journal: The Lancet. Neurology20090101

Title: Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics20090101

Title: Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.

Journal: British journal of pharmacology20090101

Title: Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex.

Journal: Journal of Alzheimer's disease : JAD20090101

Title: Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.

Journal: CNS drugs20090101

Title: Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network.

Journal: Dementia and geriatric cognitive disorders20090101

Title: Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.

Journal: Drugs & aging20090101

Title: Verbal repetition in people with mild-to-moderate Alzheimer Disease: a descriptive analysis from the VISTA clinical trial.

Journal: Alzheimer disease and associated disorders20090101

Title: Synthesis and characterization of new galanthamine derivatives comprising peptide moiety.

Journal: Protein and peptide letters20090101

Title: Optimized nutrient medium for galanthamine production in Leucojum aestivum L. in vitro shoot system.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences20090101

Title: Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study.

Journal: Drugs & aging20090101

Title: [Galantamine (reminyl) in the treatment of severe Alzheimer's disease].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20090101

Title: Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?

Journal: Dementia and geriatric cognitive disorders20090101

Title: Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.

Journal: CNS neuroscience & therapeutics20090101

Title: Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.

Journal: Dementia and geriatric cognitive disorders20090101

Title: [The use of reminyl (galantamine) in the treatment of probable vascular dementia].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20090101

Title: [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20090101

Title: Modeling the cost-effectiveness of galantamine for mild to moderately severe Alzheimer's disease in Korea.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research20090101

Title: Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.

Journal: Neuroscience letters20081219

Title: Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.

Journal: Neuroscience research20081201

Title: Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease.

Journal: American journal of Alzheimer's disease and other dementias20081201

Title: Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*.

Journal: Current medical research and opinion20081201

Title: Effects of cholinotropic and cytostatic drugs on the development of Arthus reaction.

Journal: Bulletin of experimental biology and medicine20081201

Title: Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: part I.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V20081101

Title: Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).

Journal: Neuroscience and behavioral physiology20081101

Title: [Bradycardia induced by galantamine].

Journal: Annales francaises d'anesthesie et de reanimation20081101

Title: Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor.

Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)20081101

Title: Domino double Michael-Claisen cyclizations: a powerful general tool for introducing quaternary stereocenters at C4 of cyclohexane-1,3-diones and total synthesis of diverse families of sterically congested alkaloids.

Journal: The Journal of organic chemistry20081003

Title: Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial.

Journal: International psychogeriatrics20081001

Title: Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.

Journal: British journal of pharmacology20081001

Title: Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro.

Journal: Journal of neural transmission (Vienna, Austria : 1996)20081001

Title: Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).

Journal: Journal of psychopharmacology (Oxford, England)20080901

Title: Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.

Journal: The international journal of neuropsychopharmacology20080901

Title: An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.

Journal: Cerebrovascular diseases (Basel, Switzerland)20080901

Title: Spinal p38 MAP kinase regulates peripheral cholinergic outflow.

Journal: Arthritis and rheumatism20080901

Title: [Galantamine].

Journal: Revue de l'infirmiere20080901

Title: [Galantamine therapy in dementia associated with CADASIL].

Journal: Revista de neurologia20080901

Title: The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet20080901

Title: Drug utilization review of cholinesterase inhibitors in Quebec.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques20080901

Title: PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.

Journal: Neurobiology of aging20080801

Title: Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.

Journal: Schizophrenia research20080801

Title: The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.

Journal: Epilepsy & behavior : E&B20080801

Title: Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.

Journal: Schizophrenia research20080801

Title: A nonlinear mixed effects IVIVC model for multi-release drug delivery systems.

Journal: Journal of pharmacokinetics and pharmacodynamics20080801

Title: Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: brain ACh increasing and memory improving properties.

Journal: Biochemical pharmacology20080715

Title: High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.

Journal: Schizophrenia research20080701

Title: Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.

Journal: Molecular pharmacology20080701

Title: Prevalence of cholinesterase inhibitors in subjects with dementia in Europe.

Journal: Pharmacoepidemiology and drug safety20080701

Title: The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.

Journal: Journal of psychiatric research20080601

Title: A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.

Journal: International journal of geriatric psychiatry20080601

Title: Galantamine as an adjunctive treatment in major depression.

Journal: Journal of clinical psychopharmacology20080601

Title: Hydrogen-bonding properties of galanthamine: an investigation through crystallographic database observations and computational chemistry.

Journal: Acta crystallographica. Section B, Structural science20080601

Title: Galantamine-induced pisa syndrome: memantine as an alternative.

Journal: International journal of geriatric psychiatry20080601

Title: Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.

Journal: Journal of managed care pharmacy : JMCP20080601

Title: Safety and efficacy of galantamine in subjects with mild cognitive impairment.

Journal: Neurology20080527

Title: Treatment for MCI: is the evidence sufficient?

Journal: Neurology20080527

Title: Dementia medications in palliative care #174.

Journal: Journal of palliative medicine20080501

Title: Galantamine improves gait performance in patients with Alzheimer's disease.

Journal: Journal of the American Geriatrics Society20080501

Title: [Treatment of Alzheimer's disease: status quo and future considerations].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20080501

Title: Diagnosis and treatment of dementia with Lewy bodies.

Journal: JAAPA : official journal of the American Academy of Physician Assistants20080501

Title: AAFP and ACP release guideline on dementia treatment.

Journal: American family physician20080415

Title: For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?

Journal: International psychogeriatrics20080401

Title: N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum.

Journal: Bioorganic & medicinal chemistry letters20080401

Title: Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction.

Journal: Biochemical and biophysical research communications20080314

Title: Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations.

Journal: Annals of internal medicine20080304

Title: Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

Journal: Annals of internal medicine20080304

Title: Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.

Journal: Annals of internal medicine20080304

Title: Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells.

Journal: Neurotoxicology20080301

Title: Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine.

Journal: Neurobiology of aging20080201

Title: Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

Journal: International journal of geriatric psychiatry20080201

Title: A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.

Journal: International journal of geriatric psychiatry20080201

Title: Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.

Journal: International journal of geriatric psychiatry20080201

Title: Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology20080201

Title: Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.

Journal: International journal of geriatric psychiatry20080201

Title: Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.

Journal: Psychopharmacology20080201

Title: Prolonged QT interval, syncope, and delirium with galantamine.

Journal: The Annals of pharmacotherapy20080201

Title: Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study.

Journal: Journal of Korean medical science20080201

Title: Pharmacologic management of Alzheimer disease.

Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses20080201

Title: [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?].

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke20080131

Title: [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].

Journal: Der Nervenarzt20080101

Title: Galantamine for the treatment of cognitive impairments in people with schizophrenia.

Journal: The American journal of psychiatry20080101

Title: Galantamine in Alzheimer's disease.

Journal: Expert review of neurotherapeutics20080101

Title: Galantamine in frontotemporal dementia and primary progressive aphasia.

Journal: Dementia and geriatric cognitive disorders20080101

Title: First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy.

Journal: Clinical neuropharmacology20080101

Title: Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil.

Journal: Alzheimer disease and associated disorders20080101

Title: Analysis of galanthamine-type alkaloids by capillary gas chromatography-mass spectrometry in plants.

Journal: Phytochemical analysis : PCA20080101

Title: New rapid validated HPTLC method for the determination of galanthamine in Amaryllidaceae plant extracts.

Journal: Phytochemical analysis : PCA20080101

Title: The clinical significance of plasmatic amyloid A{beta}-40 peptide levels in Alzheimer's disease patients treated with galantamine.

Journal: American journal of Alzheimer's disease and other dementias20080101

Title: One-week dose titration of extended release galantamine in patients with Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association20080101

Title: Review of issue: studies on veterans, a useful pain scale, and plasma amyloid levels as a predictor of response to medications.

Journal: American journal of Alzheimer's disease and other dementias20080101

Title: [Combined use of reminyl (galanthamine) and ovestin (oestradiol) for the treatment of cognitive disorders in women with hypoestrogenic syndrome].

Journal: Eksperimental'naia i klinicheskaia farmakologiia20080101

Title: Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.

Journal: Clinical interventions in aging20080101

Title: Combined models for data from in vitro-in vivo correlation experiments.

Journal: Journal of biopharmaceutical statistics20080101

Title: Intranasal administration of acetylcholinesterase inhibitors.

Journal: BMC neuroscience20080101

Title: Electrically enhanced and controlled drug delivery through buccal mucosa.

Journal: Acta poloniae pharmaceutica20080101

Title: Discontinuing Alzheimer's disease drug therapy: why, when, and how.

Journal: Director (Cincinnati, Ohio)20080101

Title: Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy.

Journal: Stroke20071201

Title: An update on the pharmacology of galantamine.

Journal: Expert opinion on investigational drugs20071201

Title: Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.

Journal: Psychiatry and clinical neurosciences20071201

Title: Suzuki-Miyaura and Stille reactions as key steps in the synthesis of diversely functionalized Amaryllidaceae alkaloid analogs bearing a 5,6,7,8-tetrahydrobenzo[c,e]azocine skeleton.

Journal: Combinatorial chemistry & high throughput screening20071101

Title: Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society20071015

Title: Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.

Journal: Neurology20071009

Title: Impairments in trace EB conditioning by knife-cut lesions to the fornix in rabbits: reversal by galantamine.

Journal: Neurobiology of learning and memory20071001

Title: Evaluation of centrally acting cholinesterase inhibitor exposures in adults.

Journal: The Annals of pharmacotherapy20071001

Title: Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.

Journal: Prescrire international20071001

Title: Diagnosis and management of vascular cognitive impairment.

Journal: Current atherosclerosis reports20071001

Title: [The localization of galanthamine in vegetative organ of Lycoris aurea Herb].

Journal: Fen zi xi bao sheng wu xue bao = Journal of molecular cell biology20071001

Title: [Are anti-dementia drugs worthwhile?].

Journal: MMW Fortschritte der Medizin20070913

Title: Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.

Journal: International journal of geriatric psychiatry20070901

Title: Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.

Journal: Neuropharmacology20070901

Title: Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.

Journal: The Lancet. Neurology20070901

Title: NICE judgement leaves behind a nasty taste.

Journal: Nursing older people20070901

Title: The enantioselective synthesis of (-)-lycoramine with the Birch-Cope sequence.

Journal: The Journal of organic chemistry20070831

Title: Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.

Journal: Neurology20070821

Title: Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils.

Journal: The Journal of pharmacology and experimental therapeutics20070801

Title: Galantamine treatment of vascular dementia: a randomized trial.

Journal: Neurology20070731

Title: Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease.

Journal: Magnetic resonance imaging20070701

Title: Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.

Journal: The Journal of pharmacology and experimental therapeutics20070701

Title: Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology.

Journal: Journal of Alzheimer's disease : JAD20070701

Title: High-performance liquid chromatographic method with UV photodiode-array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20070615

Title: Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.

Journal: Journal of molecular biology20070615

Title: Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats.

Journal: The international journal of neuropsychopharmacology20070601

Title: Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20070601

Title: The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20070601

Title: The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.

Journal: The Journal of pharmacology and experimental therapeutics20070601

Title: Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future.

Journal: International psychogeriatrics20070601

Title: [Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies].

Journal: Deutsche medizinische Wochenschrift (1946)20070601

Title: [Galanthamine versus donepezil in the treatment of Alzheimer's disease].

Journal: Revista de neurologia20070601

Title: Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.

Journal: Die Pharmazie20070601

Title: A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels.

Journal: Journal of Alzheimer's disease : JAD20070601

Title: [Acetylcholinesterase inhibitors for dementia--an update].

Journal: MMW Fortschritte der Medizin20070521

Title: Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.

Journal: Neurology20070515

Title: Stereocontrolled synthesis of (-)-galanthamine.

Journal: Organic letters20070510

Title: In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.

Journal: International journal of pharmaceutics20070420

Title: Post-ischemic continuous administration of galantamine attenuates cognitive deficits and hippocampal neurons loss after transient global ischemia in gerbils.

Journal: Neuroscience letters20070406

Title: Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.

Journal: Neurology20070403

Title: Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.

Journal: International journal of geriatric psychiatry20070401

Title: The influence of galantamine on reaction time, attention processes, and performance variability in elderly Alzheimer patients.

Journal: Journal of clinical psychopharmacology20070401

Title: Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.

Journal: Age and ageing20070301

Title: A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.

Journal: International clinical psychopharmacology20070301

Title: A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.

Journal: International journal of clinical practice20070301

Title: Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.

Journal: Neuropharmacology20070301

Title: Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.

Journal: Pharmacotherapy20070301

Title: Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.

Journal: The Journal of clinical psychiatry20070301

Title: Pharmacokinetics and bioequivalence studies of galantamine hydrobromide dispersible tablet in healthy male Chinese volunteers.

Journal: Drug development and industrial pharmacy20070301

Title: Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats.

Journal: Neuropharmacology20070201

Title: Anti-Alzheimer drugs: life-threatening adverse effects.

Journal: Prescrire international20070201

Title: Quantitative determination of galantamine in human plasma by sensitive liquid chromatography-tandem mass spectrometry using loratadine as an internal standard.

Journal: Journal of chromatographic science20070201

Title: Nicotinic component of galantamine in the regulation of amyloid precursor protein processing.

Journal: Chemico-biological interactions20070130

Title: Changes of cholinesterase activities in the plasma and some tissues following administration of L-carnitine and galanthamine to rats.

Journal: Neuroscience letters20070116

Title: Preparation of secolycorines against acetylcholinesterase.

Journal: Bioorganic & medicinal chemistry20070115

Title: Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20070101

Title: Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.

Journal: Synapse (New York, N.Y.)20070101

Title: Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials.

Journal: Drugs & aging20070101

Title: Effect of a M1 allosteric modulator on scopolamine-induced amnesia.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))20070101

Title: Galantamine and QTc prolongation.

Journal: The Journal of clinical psychiatry20070101

Title: Posttraumatic stress disorder-like symptoms after treatment with acetylcholinesterase inhibitors.

Journal: The Journal of neuropsychiatry and clinical neurosciences20070101

Title: Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).

Journal: Archives of gerontology and geriatrics20070101

Title: Results of galantamine treatment in acute traumatic brain injury.

Journal: Psychosomatics20070101

Title: Brain activation in elderly people with and without dementia: Influences of gender and medication.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry20070101

Title: Naturalistic treatment of Alzheimer's disease with galantamine: 12-month follow-up from the NATURE study.

Journal: CNS drugs20070101

Title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.

Journal: Dementia and geriatric cognitive disorders20070101

Title: Galantamine for Alzheimer's disease and mild cognitive impairment.

Journal: Neuroepidemiology20070101

Title: Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats.

Journal: Cell transplantation20070101

Title: [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].

Journal: Fiziologiia cheloveka20070101

Title: Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis.

Journal: PharmacoEconomics20070101

Title: [Alzheimer drugs for mild cognitive impairment].

Journal: Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater20070101

Title: [Criminal clozapine intoxications].

Journal: Anesteziologiia i reanimatologiia20070101

Title: Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

Journal: Drug safety20070101

Title: Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.

Journal: Current medicinal chemistry20070101

Title: Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis.

Journal: Journal of neural transmission. Supplementum20070101

Title: Alkaloid variability in Leucojum aestivum from wild populations.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences20070101

Title: [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20070101

Title: In vitro galantamine-memantine co-application: mechanism of beneficial action.

Journal: Neuropharmacology20061201

Title: The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.

Journal: British journal of pharmacology20061201

Title: Biomimetic synthesis of (+/-)-galanthamine and asymmetric synthesis of (-)-galanthamine using remote asymmetric induction.

Journal: Chemical & pharmaceutical bulletin20061201

Title: Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.

Journal: Neuro endocrinology letters20061201

Title: Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.

Journal: International journal of clinical pharmacology and therapeutics20061201

Title: 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.

Journal: Bioorganic & medicinal chemistry letters20061115

Title: Micellar electrokinetic chromatography-electrospray ionization mass spectrometry for the identification of drug impurities.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20061107

Title: Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.

Journal: European journal of pharmacology20061107

Title: Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.

Journal: Journal of psychiatry & neuroscience : JPN20061101

Title: Blockade of Ca2+ -activated K+ channels by galantamine can also contribute to the potentiation of catecholamine secretion from chromaffin cells.

Journal: European journal of pharmacology20061024

Title: Augmentation of near infrared diffuse reflectance and transmittance spectral data for the development of robust PLSBC models for classifying double blind clinical trial tablets.

Journal: Journal of pharmaceutical and biomedical analysis20061011

Title: [Medical treatment of Alzheimer's disease].

Journal: Ugeskrift for laeger20061002

Title: [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].

Journal: Revista de neurologia20061001

Title: Use of antidementia agents in vascular dementia: beyond Alzheimer disease.

Journal: Mayo Clinic proceedings20061001

Title: A prospective, open-label trial of galantamine in autistic disorder.

Journal: Journal of child and adolescent psychopharmacology20061001

Title: Galantamine improves cognition in schizophrenic patients stabilized on risperidone.

Journal: Biological psychiatry20060915

Title: Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment.

Journal: Toxicology in vitro : an international journal published in association with BIBRA20060901

Title: Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.

Journal: The Journal of pharmacology and experimental therapeutics20060901

Title: [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].

Journal: Revista clinica espanola20060901

Title: Harmless herbs? Think again: merits of a complete medication history.

Journal: Journal of the American Medical Directors Association20060901

Title: Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval.

Journal: Pharmacology, biochemistry, and behavior20060901

Title: Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana.

Journal: Journal of natural products20060901

Title: Adjuvant galantamine for cognitive dysfunction in a patient with bipolar disorder.

Journal: Journal of psychiatric practice20060901

Title: Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.

Journal: Proceedings of the National Academy of Sciences of the United States of America20060829

Title: [Advances in Alzheimer's disease treatment].

Journal: La Revue de medecine interne20060801

Title: [Cholinesterase inhibitor therapy in long term care settings].

Journal: La Revue de medecine interne20060801

Title: [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan20060801

Title: Alzheimer's disease.

Journal: Lancet (London, England)20060729

Title: [Mortality-associated factors in patients with Alzheimer's disease treated with galantamine].

Journal: Medicina clinica20060708

Title: Galantamine added to antipsychotic treatment in chronic schizophrenia: cognitive improvement?

Journal: Schizophrenia research20060701

Title: Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.

Journal: Age and ageing20060701

Title: Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.

Journal: Journal of clinical pharmacology20060701

Title: Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Journal: Journal of clinical pharmacology20060701

Title: Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry20060701

Title: Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged rats.

Journal: Pharmacology, biochemistry, and behavior20060701

Title: Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia.

Journal: Journal of pharmacological sciences20060701

Title: Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery.

Journal: Journal of pharmaceutical sciences20060601

Title: Alzheimer's disease: beware of interactions with cholinesterase inhibitors.

Journal: Prescrire international20060601

Title: Once-daily formulation of galantamine.

Journal: Journal of the American Medical Directors Association20060601

Title: [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].

Journal: Medizinische Monatsschrift fur Pharmazeuten20060601

Title: Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.

Journal: The American journal of geriatric pharmacotherapy20060601

Title: [Anti-dementia drugs for dementia syndromes--just unkept promises?].

Journal: MMW Fortschritte der Medizin20060515

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen.

Journal: International journal of clinical practice20060501

Title: [Complete atrioventricular block during galantamine therapy].

Journal: Nederlands tijdschrift voor geneeskunde20060429

Title: Total synthesis of (+/-)-galanthamine.

Journal: Organic letters20060427

Title: An innovative approach to involve patients in measuring treatment effects in drug trials.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne20060411

Title: Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne20060411

Title: Clinical trials in mild cognitive impairment: lessons for the future.

Journal: Journal of neurology, neurosurgery, and psychiatry20060401

Title: Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice.

Journal: The Journal of pharmacology and experimental therapeutics20060401

Title: Accurate product ion mass spectra of galanthamine derivatives.

Journal: Journal of mass spectrometry : JMS20060401

Title: Galantamine treatment of cognitive impairment in bipolar disorder: four cases.

Journal: Bipolar disorders20060401

Title: A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study.

Journal: Journal of clinical psychopharmacology20060401

Title: Antiamnesic effect of combined treatment with galantamine and estradiol in middle-aged ovariectomized female rats.

Journal: Bulletin of experimental biology and medicine20060401

Title: [Complete atrioventricular block during galantamine therapy].

Journal: Nederlands tijdschrift voor geneeskunde20060311

Title: Galantamine may improve attention and speech in schizophrenia.

Journal: Human psychopharmacology20060301

Title: Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice.

Journal: Journal of Alzheimer's disease : JAD20060301

Title: Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study.

Journal: Clinical therapeutics20060301

Title: Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.

Journal: The Journal of pharmacology and experimental therapeutics20060201

Title: Galantamine for Alzheimer's disease and mild cognitive impairment.

Journal: The Cochrane database of systematic reviews20060125

Title: Galantamine for vascular cognitive impairment.

Journal: The Cochrane database of systematic reviews20060125

Title: Cholinesterase inhibitors for Alzheimer's disease.

Journal: The Cochrane database of systematic reviews20060125

Title: Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology20060101

Title: Galantamine increases excitability of CA1 hippocampal pyramidal neurons.

Journal: Neuroscience20060101

Title: Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.

Journal: Brain : a journal of neurology20060101

Title: Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.

Journal: Dementia and geriatric cognitive disorders20060101

Title: Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis.

Journal: Neurobiology of aging20060101

Title: A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.

Journal: International journal of geriatric psychiatry20060101

Title: Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial.

Journal: Psychopharmacology20060101

Title: Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs.

Journal: International journal of geriatric psychiatry20060101

Title: Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.

Journal: Expert opinion on investigational drugs20060101

Title: Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy.

Journal: Dementia and geriatric cognitive disorders20060101

Title: Synthesis and pharmacology of galantamine.

Journal: Chemical reviews20060101

Title: Preventing protein secretion with chemical glue.

Journal: Nature chemical biology20060101

Title: The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Journal: Health technology assessment (Winchester, England)20060101

Title: Galantamine-induced QTc prolongation.

Journal: The Journal of clinical psychiatry20060101

Title: Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease.

Journal: Journal of physiology, Paris20060101

Title: [Use of reminyl (galantamine) in the treatment of dementia].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20060101

Title: Neuroprotection in vascular dementia.

Journal: Cerebrovascular diseases (Basel, Switzerland)20060101

Title: Current and emerging pharmacological treatment options for dementia.

Journal: Behavioural neurology20060101

Title: [Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease].

Journal: Neurologia (Barcelona, Spain)20060101

Title: Galantamine extended release.

Journal: CNS drugs20060101

Title: Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.

Journal: Drugs & aging20060101

Title: [Optimizing effect of the combined administration of 8-OH-DPAT and galantamine on depression--anxiety behavior in old rats with dementia of Alzheimer's type].

Journal: Eksperimental'naia i klinicheskaia farmakologiia20060101

Title: Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation.

Journal: Current medicinal chemistry20060101

Title: [Pharmacotherapy for Alzheimer's disease].

Journal: Tijdschrift voor psychiatrie20060101

Title: Kinetics of 13 new cholinesterase inhibitors.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences20060101

Title: Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.

Journal: The Journal of international medical research20060101

Title: A naturalistic study of galantamine for Alzheimer's disease.

Journal: CNS drugs20060101

Title: Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.

Journal: Rapid communications in mass spectrometry : RCM20060101

Title: Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients.

Journal: Drug safety20060101

Title: Realistic expectations for treatment success in Alzheimer's disease.

Journal: The journal of nutrition, health & aging20060101

Title: Galantamine extended release in Alzheimer's disease: profile report.

Journal: Drugs & aging20060101

Title: Alzheimer disease and its management: a review.

Journal: American journal of therapeutics20060101

Title: The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease.

Journal: Journal of molecular neuroscience : MN20060101

Title: Galanthamine, a natural product for the treatment of Alzheimer's disease.

Journal: Recent patents on CNS drug discovery20060101

Title: Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.

Journal: European journal of pharmacology20051219

Title: Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment.

Journal: Behavioural brain research20051207

Title: Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.

Journal: Neuroscience letters20051202

Title: Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20051201

Title: Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.

Journal: The Journal of pharmacology and experimental therapeutics20051201

Title: A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy.

Journal: Clinical neurology and neurosurgery20051201

Title: Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A.

Journal: Journal of natural products20051201

Title: Galantamine antiacetylcholinesterase activity in rat brain influenced by L-carnitine.

Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia20051201

Title: Dementia.

Journal: Clinical evidence20051201

Title: Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.

Journal: Brain research20051109

Title: Behavioral and neuropsychiatric outcomes in Alzheimer's disease.

Journal: CNS spectrums20051101

Title: A case report of paranoid delusion with galantamine use.

Journal: Journal of the American Geriatrics Society20051101

Title: Divergent enantioselective synthesis of (-)-galanthamine and (-)-morphine.

Journal: Journal of the American Chemical Society20051026

Title: Reduction of voluntary ethanol consumption in alcohol-preferring Alko alcohol (AA) rats by desoxypeganine and galanthamine.

Journal: European journal of pharmacology20051017

Title: Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.

Journal: Journal of clinical psychopharmacology20051001

Title: Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

Journal: Journal of neurology, neurosurgery, and psychiatry20051001

Title: Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.

Journal: Current medical research and opinion20051001

Title: New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors.

Journal: Mini reviews in medicinal chemistry20051001

Title: UK government guidance on Alzheimer's drugs postponed.

Journal: Drug discovery today20050901

Title: Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.

Journal: Current medical research and opinion20050901

Title: [Traditional dementia concepts in transition--must we change our views?].

Journal: Der Nervenarzt20050901

Title: Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.

Journal: Behavioural brain research20050830

Title: Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

Journal: BMJ (Clinical research ed.)20050806

Title: Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells.

Journal: British journal of pharmacology20050801

Title: Development of a novel high-concentration galantamine formulation suitable for intranasal delivery.

Journal: Journal of pharmaceutical sciences20050801

Title: Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity.

Journal: British journal of pharmacology20050701

Title: A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease.

Journal: European journal of clinical pharmacology20050701

Title: Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years.

Journal: International journal of clinical practice20050701

Title: [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].

Journal: Tijdschrift voor gerontologie en geriatrie20050701

Title: Predicting drug metabolism--an evaluation of the expert system METEOR.

Journal: Chemistry & biodiversity20050701

Title: Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: a PET study in monkeys.

Journal: Synapse (New York, N.Y.)20050615

Title: Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Journal: Psychopharmacology20050601

Title: Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.

Journal: CNS spectrums20050601

Title: Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials.

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry20050601

Title: [Changing the anticholinesterase in Alzheimer's disease].

Journal: Revista de neurologia20050601

Title: Galantamine: excess mortality.

Journal: Prescrire international20050601

Title: Stimulation of nicotinic acetylcholine receptors protects motor neurons.

Journal: Biochemical and biophysical research communications20050520

Title: Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects.

Journal: Journal of clinical pharmacology20050501

Title: Switching from donepezil to galantamine: a double-blind study of two wash-out periods.

Journal: International journal of geriatric psychiatry20050501

Title: Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.

Journal: Archives of neurology20050501

Title: A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.

Journal: Human psychopharmacology20050401

Title: Capillary electrophoresis-mass spectrometry in impurity profiling of pharmaceutical products.

Journal: Electrophoresis20050401

Title: [Cost-effectiveness of galantamine in a german context].

Journal: Psychiatrische Praxis20050401

Title: Actions of tacrine and galanthamine on histamine-N-methyltransferase.

Journal: Methods and findings in experimental and clinical pharmacology20050401

Title: Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation.

Journal: Current medical research and opinion20050401

Title: [Determination of galanthamine in bulb of Lycoris radiata by RP-HPLC].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica20050401

Title: Cholinesterase inhibitors in the treatment of dementia.

Journal: The Journal of the American Osteopathic Association20050301

Title: Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.

Journal: Journal of the American Academy of Nurse Practitioners20050301

Title: Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience20050223

Title: Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.

Journal: European journal of pharmacology20050221

Title: Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.

Journal: Brain research20050208

Title: Regulatory authorities review use of galantamine in mild cognitive impairment.

Journal: BMJ (Clinical research ed.)20050205

Title: Butyrylcholinesterase inhibitory guaianolides from Amberboa ramosa.

Journal: Archives of pharmacal research20050201

Title: Indicators of neuroprotection with galantamine.

Journal: Brain research bulletin20050130

Title: Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats.

Journal: Behavioural brain research20050106

Title: Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients.

Journal: Progress in neuro-psychopharmacology & biological psychiatry20050101

Title: Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literature.

Journal: International journal of geriatric psychiatry20050101

Title: Look-alike, sound-alike drug errors with Reminyl and Amaryl.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20050101

Title: Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.

Journal: Dementia and geriatric cognitive disorders20050101

Title: [Treatment of dementia].

Journal: Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics20050101

Title: Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease.

Journal: Dementia and geriatric cognitive disorders20050101

Title: The effect of galantamine added to clozapine on cognition of five patients with schizophrenia.

Journal: Clinical neuropharmacology20050101

Title: Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.

Journal: Dementia and geriatric cognitive disorders20050101

Title: Drug therapy of dementia in elderly patients. A review.

Journal: Nordic journal of psychiatry20050101

Title: Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.

Journal: American journal of Alzheimer's disease and other dementias20050101

Title: [Reminyl efficacy in dementia with Levi bodies].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20050101

Title: Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study.

Journal: Alzheimer disease and associated disorders20050101

Title: Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.

Journal: The Journal of neuropsychiatry and clinical neurosciences20050101

Title: [Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia].

Journal: Revista espanola de salud publica20050101

Title: Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.

Journal: Biochemical and biophysical research communications20041217

Title: The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.

Journal: Journal of the American Chemical Society20041201

Title: Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study.

Journal: NeuroImage20041201

Title: Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient.

Journal: The Journal of clinical psychiatry20041201

Title: Improved production of galanthamine and related alkaloids by methyl jasmonate in Narcissus confusus shoot-clumps.

Journal: Planta medica20041201

Title: Dementia.

Journal: Clinical evidence20041201

Title: Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.

Journal: Brain research. Molecular brain research20041124

Title: Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.

Journal: Journal of the neurological sciences20041115

Title: Switching from donepezil or rivastigmine to galantamine in clinical practice.

Journal: Journal of the American Geriatrics Society20041101

Title: Mechanisms of action of cognitive enhancers on neuroreceptors.

Journal: Biological & pharmaceutical bulletin20041101

Title: Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.

Journal: European journal of neurology20041101

Title: An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.

Journal: Current medical research and opinion20041101

Title: Effects of galantamine in patients with mild Alzheimer's disease.

Journal: Current medical research and opinion20041101

Title: Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.

Journal: European journal of pharmacology20041025

Title: Galantamine for Alzheimer's disease.

Journal: The Cochrane database of systematic reviews20041018

Title: Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology20041001

Title: Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.

Journal: Movement disorders : official journal of the Movement Disorder Society20041001

Title: A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population.

Journal: Clinical therapeutics20041001

Title: In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract.

Journal: European journal of pharmacology20040913

Title: Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial.

Journal: JAMA20040908

Title: Pharmacotherapy of chronic fatigue syndrome: another gallant attempt.

Journal: JAMA20040908

Title: Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons.

Journal: The Journal of pharmacology and experimental therapeutics20040901

Title: Evidence-based pharmacotherapy of Alzheimer's disease.

Journal: The international journal of neuropsychopharmacology20040901

Title: Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release.

Journal: Molecular pharmacology20040901

Title: Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons.

Journal: Molecular pharmacology20040901

Title: The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.

Journal: Expert opinion on drug safety20040901

Title: Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase.

Journal: Neuropharmacology20040901

Title: Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120.

Journal: Brain research bulletin20040830

Title: [Drug-cholinesterase-inhibitors persistence patterns in treated patients with dementia of Alzheimer type: retrospective comparative analysis of donepezil, rivastigmine and galantamine].

Journal: Revista de neurologia20040801

Title: Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation.

Journal: Neuroscience letters20040722

Title: A case study in the treatment of dementia with Lewy bodies.

Journal: Acta psychiatrica Scandinavica20040701

Title: Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease.

Journal: Journal of the American Geriatrics Society20040701

Title: Understanding the latest advances in pharmacologic interventions for Alzheimer's disease.

Journal: CNS spectrums20040701

Title: [Galantamine, an acetylcholinesterase inhibitor with various actions].

Journal: Medizinische Monatsschrift fur Pharmazeuten20040701

Title: Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats.

Journal: The Journal of pharmacology and experimental therapeutics20040601

Title: Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge.

Journal: Journal of ethnopharmacology20040601

Title: Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.

Journal: Current medical research and opinion20040601

Title: Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.

Journal: International journal of geriatric psychiatry20040601

Title: Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01).

Journal: Arquivos de neuro-psiquiatria20040601

Title: ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study.

Journal: Collegium antropologicum20040601

Title: Dementia.

Journal: Clinical evidence20040601

Title: Total synthesis of (-)-galanthamine by remote asymmetric induction.

Journal: Angewandte Chemie (International ed. in English)20040510

Title: The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease.

Journal: CNS spectrums20040501

Title: Drug therapy for Alzheimer's disease.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne20040427

Title: Emerging therapies for vascular dementia and vascular cognitive impairment.

Journal: Stroke20040401

Title: Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease.

Journal: Current medical research and opinion20040401

Title: Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.

Journal: The American journal of psychiatry20040301

Title: Galantamine: use in Alzheimer's disease and related disorders.

Journal: Expert review of neurotherapeutics20040301

Title: The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial.

Journal: Archives of neurology20040201

Title: A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease.

Journal: International journal of clinical practice20040201

Title: Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine.

Journal: Dementia and geriatric cognitive disorders20040101

Title: Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.

Journal: Neuropharmacology20040101

Title: Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.

Journal: Neuropharmacology20040101

Title: Pharmacologic treatment expectations in the management of dementia with Lewy bodies.

Journal: Dementia and geriatric cognitive disorders20040101

Title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis.

Journal: Dementia and geriatric cognitive disorders20040101

Title: A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.

Journal: International journal of geriatric psychiatry20040101

Title: Galantamine facilitates acquisition of hippocampus-dependent trace eyeblink conditioning in aged rabbits.

Journal: Learning & memory (Cold Spring Harbor, N.Y.)20040101

Title: Galantamine facilitates acquisition of a trace-conditioned eyeblink response in healthy, young rabbits.

Journal: Learning & memory (Cold Spring Harbor, N.Y.)20040101

Title: Acetylcholinesterase inhibition in Alzheimer's Disease.

Journal: Current pharmaceutical design20040101

Title: Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat.

Journal: Arzneimittel-Forschung20040101

Title: Treatment of Huntington's disease with galantamine.

Journal: International clinical psychopharmacology20040101

Title: Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Journal: Drugs & aging20040101

Title: [Drug therapy for aged patients with Alzheimer disease].

Journal: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica20040101

Title: [The virtual synapse what is its contribution to understanding cholinergic neural transmission?].

Journal: Therapie20040101

Title: Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a 'real world' study.

Journal: Archives of gerontology and geriatrics. Supplement20040101

Title: What are the treatment options for patients with severe Alzheimer's disease?

Journal: CNS drugs20040101

Title: The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?

Journal: Journal of the American Medical Directors Association20040101

Title: Wernicke-Korsakoff syndrome and galantamine.

Journal: Psychosomatics20040101

Title: Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.

Journal: Dementia and geriatric cognitive disorders20040101

Title: Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease.

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry20040101

Title: Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors.

Journal: Alzheimer disease and associated disorders20040101

Title: Noncognitive symptoms and long-term treatment expectations for Alzheimer disease.

Journal: Alzheimer disease and associated disorders20040101

Title: The needs of the caregiver in the long-term treatment of Alzheimer disease.

Journal: Alzheimer disease and associated disorders20040101

Title: Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries.

Journal: Drugs & aging20040101

Title: Long-term outcomes of galantamine treatment in patients with Alzheimer disease.

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry20040101

Title: Alleviation of multiple abnormalities by galantamine treatment in two patients with dementia with Lewy bodies.

Journal: American journal of Alzheimer's disease and other dementias20040101

Title: Molecular recognition between 4a S/R-galanthamine diastereoisomers and alpha-cyclodextrin.

Journal: Journal of molecular modeling20031201

Title: Galanthamine distribution in Bulgarian Galanthus spp.

Journal: Die Pharmazie20031201

Title: Galanthamine pattern in Narcissus confusus plants.

Journal: Planta medica20031201

Title: A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD20031201

Title: Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.

Journal: Prescrire international20031201

Title: The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.

Journal: Molecular pharmacology20031101

Title: Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease.

Journal: European journal of neurology20031101

Title: Editorial comment--How to treat vascular dementia?

Journal: Stroke20031001

Title: Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.

Journal: International journal of geriatric psychiatry20031001

Title: The effects of galantamine treatment on caregiver time in Alzheimer's disease.

Journal: International journal of geriatric psychiatry20031001

Title: Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependent.

Journal: Life sciences20030919

Title: (-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old rats.

Journal: Neurobiology of learning and memory20030901

Title: Update on Alzheimer drugs (galantamine).

Journal: The neurologist20030901

Title: Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.

Journal: International journal of geriatric psychiatry20030801

Title: Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine.

Journal: Sleep20030801

Title: Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.

Journal: Bioorganic & medicinal chemistry letters20030721

Title: [Acetylcholinesterase inhibitors].

Journal: Revue medicale de la Suisse romande20030701

Title: Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20030615

Title: Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.

Journal: The Journal of pharmacology and experimental therapeutics20030601

Title: An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.

Journal: Clinical therapeutics20030601

Title: Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States.

Journal: Clinical therapeutics20030601

Title: Dementia.

Journal: Clinical evidence20030601

Title: The impact of drugs against dementia on cognition in aging and mild cognitive impairment.

Journal: Pharmacopsychiatry20030601

Title: [Current therapy of patients with dementia].

Journal: MMW Fortschritte der Medizin20030526

Title: Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase.

Journal: Biosensors & bioelectronics20030501

Title: Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations.

Journal: Journal of clinical pharmacology20030501

Title: Galantamine.

Journal: The Israel Medical Association journal : IMAJ20030501

Title: The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure.

Journal: International journal of geriatric psychiatry20030401

Title: Galantamine: a review of its use in Alzheimer's disease and vascular dementia.

Journal: International journal of clinical practice20030401

Title: Sequential designs for phase III clinical trials incorporating treatment selection.

Journal: Statistics in medicine20030315

Title: Galantamine hydrobromide: an agent for Alzheimer's disease.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20030301

Title: Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats.

Journal: Progress in neuro-psychopharmacology & biological psychiatry20030201

Title: Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.

Journal: Stroke20030201

Title: Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons.

Journal: Neuroscience letters20030109

Title: Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis.

Journal: Dementia and geriatric cognitive disorders20030101

Title: Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders.

Journal: Phytotherapy research : PTR20030101

Title: Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.

Journal: Dementia and geriatric cognitive disorders20030101

Title: Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors.

Journal: Neuroscience20030101

Title: [Zoofilia as late complication of Parkinson's disease. Circe drugs and Mercury antidotes].

Journal: Neurologia (Barcelona, Spain)20030101

Title: Antioxidant properties of galantamine hydrobromide.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences20030101

Title: A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.

Journal: Drugs & aging20030101

Title: Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.

Journal: Arzneimittel-Forschung20030101

Title: Current treatments for Alzheimer's disease: cholinesterase inhibitors.

Journal: The Journal of clinical psychiatry20030101

Title: Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Journal: CNS drugs20030101

Title: Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease.

Journal: Alzheimer disease and associated disorders20030101

Title: Clinical experience of galantamine in dementia: a series of case reports.

Journal: Current medical research and opinion20030101

Title: Capillary electrophoresis as an orthogonal technique in HPLC method validation.

Journal: Journal of capillary electrophoresis and microchip technology20030101

Title: [Mechanisms of action of Alzheimer medications].

Journal: Duodecim; laaketieteellinen aikakauskirja20030101

Title: Galantamine vs donepezil in the treatment of Alzheimer's disease.

Journal: Drugs & aging20030101

Title: Clinical pharmacokinetics of galantamine.

Journal: Clinical pharmacokinetics20030101

Title: [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20030101

Title: Galantamine in the treatment of adult autism: a report of three clinical cases.

Journal: International journal of psychiatry in medicine20030101

Title: Galantamine in the treatment of vascular dementia.

Journal: International psychogeriatrics20030101

Title: Galantamine may be effective in treating autistic disorder.

Journal: BMJ (Clinical research ed.)20021214

Title: [Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office].

Journal: Fortschritte der Medizin. Originalien20021205

Title: Unconventional ligands and modulators of nicotinic receptors.

Journal: Journal of neurobiology20021201

Title: Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.

Journal: Journal of clinical pharmacology20021201

Title: Treatment options: the latest evidence with galantamine (Reminyl).

Journal: Journal of the neurological sciences20021115

Title: The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.

Journal: Journal of the neurological sciences20021115

Title: Use of galantamine to treat vascular dementia.

Journal: Lancet (London, England)20021109

Title: Use of galantamine to treat vascular dementia.

Journal: Lancet (London, England)20021109

Title: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.

Journal: Current neurology and neuroscience reports20021101

Title: A novel treatment for patients with Alzheimer's disease and with vascular dementia.

Journal: Annals of the New York Academy of Sciences20021101

Title: Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine.

Journal: Annals of the New York Academy of Sciences20021101

Title: [Anti-dementia drugs for Alzheimer disease in present and future].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20021101

Title: A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat.

Journal: European journal of pharmacology20021025

Title: Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts.

Journal: Life sciences20021011

Title: The impact of journal advertisements on prescribers of cholinesterase inhibitors.

Journal: International journal of geriatric psychiatry20021001

Title: [Galantamine: a novel cholinergic agent for Alzheimer's disease].

Journal: Neurologia (Barcelona, Spain)20021001

Title: [The role of substantia nigra in the cognitive activity in cats].

Journal: Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova20021001

Title: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.

Journal: Current neurology and neuroscience reports20020901

Title: Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects.

Journal: Journal of clinical pharmacology20020901

Title: Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine.

Journal: European journal of neurology20020901

Title: Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months.

Journal: International journal of clinical practice20020901

Title: Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology20020901

Title: An efficient enantioselective synthesis of (-)-galanthamine.

Journal: Angewandte Chemie (International ed. in English)20020802

Title: Galantamine for vascular dementia.

Journal: The Lancet. Neurology20020801

Title: Galantamine for treatment-resistant schizophrenia.

Journal: The American journal of psychiatry20020701

Title: Medical treatment of Alzheimer's disease: past, present, and future.

Journal: Medicine and health, Rhode Island20020701

Title: [Nicotinic Receptor, galantamine and Alzheimer disease].

Journal: Revista de neurologia20020601

Title: The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.

Journal: International journal of clinical practice. Supplement20020601

Title: The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.

Journal: International journal of clinical practice. Supplement20020601

Title: Galanthamine as bis-functional ligand for the acetylcholinesterase.

Journal: Journal of molecular modeling20020601

Title: [Latest therapies for treating dementia].

Journal: Atencion primaria20020515

Title: The metabolism and excretion of galantamine in rats, dogs, and humans.

Journal: Drug metabolism and disposition: the biological fate of chemicals20020501

Title: The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.

Journal: Molecular pharmacology20020501

Title: Galantamine for vascular dementia: some answers, some questions.

Journal: Lancet (London, England)20020413

Title: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.

Journal: Lancet (London, England)20020413

Title: Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers.

Journal: Journal of clinical pharmacology20020401

Title: Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.

Journal: Current medical research and opinion20020101

Title: Galantamine for Alzheimer's disease.

Journal: The Cochrane database of systematic reviews20020101

Title: Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden.

Journal: PharmacoEconomics20020101

Title: Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands.

Journal: Dementia and geriatric cognitive disorders20020101

Title: [New theory! Galantamine and nicotinic-cholinergic transmission].

Journal: Pharmazie in unserer Zeit20020101

Title: Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease.

Journal: CNS drug reviews20020101

Title: New drugs 2002, part 1.

Journal: Nursing20020101

Title: Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.

Journal: PharmacoEconomics20020101

Title: Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.

Journal: International journal of technology assessment in health care20020101

Title: Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia.

Journal: Clinical neuropharmacology20020101

Title: Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy.

Journal: Journal of neural transmission. Supplementum20020101

Title: Nicotinic cholinergic modulation: galantamine as a prototype.

Journal: CNS drug reviews20020101

Title: Vascular dementia: galantamine (Reminyl) as an emerging therapeutic option.

Journal: Acta neurologica Scandinavica. Supplementum20020101

Title: Cognitive decline and treatment options for patients with vascular dementia.

Journal: Acta neurologica Scandinavica. Supplementum20020101

Title: Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementia.

Journal: Acta neurologica Scandinavica. Supplementum20020101

Title: Solid-phase extraction and reversed-phase high-performance liquid chromatography of the five major alkaloids in Narcissus confusus.

Journal: Phytochemical analysis : PCA20020101

Title: A clinical overview of cholinesterase inhibitors in Alzheimer's disease.

Journal: International psychogeriatrics20020101

Title: [Acetylcholinesterase inhibitors--beyond Alzheimer's disease].

Journal: Psychiatria polska20020101

Title: [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].

Journal: MMW Fortschritte der Medizin20011213

Title: Unsafe prescription medication switching recommendations.

Journal: Clinical therapeutics20011201

Title: Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.

Journal: Prescrire international20011201

Title: Current status and new developments with galantamine in the treatment of Alzheimer's disease.

Journal: Expert opinion on pharmacotherapy20011201

Title: [Perspectives for drug treatment in Alzheimer's disease].

Journal: Annales de medecine interne20011201

Title: Galantamine hydrobromide.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20011115

Title: Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Journal: Journal of neurology, neurosurgery, and psychiatry20011101

Title: Galantamine: a new alzheimer drug with a past life.

Journal: The Annals of pharmacotherapy20011101

Title: Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada.

Journal: Neurology20010925

Title: Sleep and the cholinergic rapid eye movement sleep induction test in patients with primary alcohol dependence.

Journal: Biological psychiatry20010901

Title: Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease.

Journal: International journal of geriatric psychiatry20010901

Title: [Anticholinesterase agents in Alzheimer's disease].

Journal: Revue medicale de Bruxelles20010901

Title: Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease.

Journal: Alzheimer disease and associated disorders20010801

Title: Maintaining cognitive function in Alzheimer disease: how effective are current treatments?

Journal: Alzheimer disease and associated disorders20010801

Title: Maintaining functional and behavioral abilities in Alzheimer disease.

Journal: Alzheimer disease and associated disorders20010801

Title: Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product.

Journal: Journal of the American Chemical Society20010711

Title: Use of cholinesterase inhibitors for treatment of Alzheimer disease.

Journal: Cleveland Clinic journal of medicine20010701

Title: Featured CME topic: dementia. Medication update.

Journal: Southern medical journal20010701

Title: Galantamine (reminyl) for Alzheimer's disease.

Journal: The Medical letter on drugs and therapeutics20010625

Title: Meeting the challenges of vascular dementia. Introduction.

Journal: International journal of clinical practice. Supplement20010501

Title: The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).

Journal: International journal of clinical practice. Supplement20010501

Title: FDA approves galantamine for Alzheimer's disease.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20010415

Title: Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.

Journal: Neuroscience letters20010316

Title: Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.

Journal: Proceedings of the National Academy of Sciences of the United States of America20010213

Title: Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs.

Journal: Proteins20010201

Title: Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.

Journal: Biological psychiatry20010201

Title: Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease.

Journal: Biological psychiatry20010201

Title: APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.

Journal: Dementia and geriatric cognitive disorders20010101

Title: Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

Journal: Health technology assessment (Winchester, England)20010101

Title: Galantamine for Alzheimer's disease.

Journal: The Cochrane database of systematic reviews20010101

Title: Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Introduction.